k.kravchenko
Submits third-party assay reports on material purchased directly. Based in Braga.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
4
n=4
Annotations
0
n=0
Median purity submitted
99.05%
n=4
Suppliers covered
4
n=4
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042428 | ARA-290 | Homopeptide | HOMO-2602-K4395 | Janoshik | 2026-Q1 | 99.42 | 4.54 | 92.9 | Buyer-sourced | 0 | PASS |
| AX-2025-020303 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2507-S2892 | VendorInvestigate | 2025-Q3 | 99.93 | 5.00 | 101.5 | Buyer-sourced | 0 | FAIL |
| AX-2025-020192 | Semaglutide | ERP | ERP-2502-K9538 | VendorInvestigate | 2025-Q3 | 98.67 | 2.28 | 93.3 | Buyer-sourced | 0 | PASS |
| AX-2025-019169 | Tirzepatide | SinoPep | SNP-2505-A3973 | Medutest | 2025-Q2 | 98.48 | 5.13 | 99.4 | Buyer-sourced | 0 | PASS |
| Supplier | Records | Median purity |
|---|---|---|
| Homopeptide | 1 | n<3 |
| GGPeps | 1 | n<3 |
| ERP | 1 | n<3 |
| SinoPep | 1 | n<3 |